C
XERS icon

Covestor’s Xeris Biopharma Holdings XERS Stock Holding History

Covestor’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
138
+118
+590% +$754 ﹤0.01% 2395
2026
Q1 		$0 Sell
20
-155
-89% -$1.03K ﹤0.01% 2834
2025
Q4 		$1K Sell
175
-146
-45% -$1.15K ﹤0.01% 2202
2025
Q3 		$3K Buy
321
+28
+10% +$186 ﹤0.01% 1905
2025
Q2 		$1K Sell
293
-86
-23% -$394 ﹤0.01% 2127
2025
Q1 		$2K Buy
+379
New +$1.53K ﹤0.01% 1904

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Covestor's XERS Position: Q2 2026 in Review

Covestor increased its Xeris Biopharma Holdings (XERS) stake by 590% in Q2 2026, buying an estimated $754 and bringing the position to 138 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2395.

Covestor first reported a position in XERS in Q1 2025 and has held it in 6 quarters since. The position peaked at $3K in Q3 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Covestor held 138 shares of Xeris Biopharma Holdings worth $1K as of Q2 2026.
  • Covestor bought 118 Xeris Biopharma Holdings shares in Q2 2026, an estimated $754.
  • Xeris Biopharma Holdings made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2395 holding.
  • Covestor first reported a position in Xeris Biopharma Holdings in Q1 2025 and has held it in 6 quarters since.
  • Covestor's Xeris Biopharma Holdings position peaked at $3K in Q3 2025.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.